chr11-47335119-C-T
Variant summary
Our verdict is Uncertain significance. Variant got 4 ACMG points: 4P and 0B. PM1PP3_Moderate
The NM_000256.3(MYBPC3):c.2828G>A(p.Arg943Gln) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000093 in 1,612,362 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_000256.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 4 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MYBPC3 | ENST00000545968.6 | c.2828G>A | p.Arg943Gln | missense_variant | Exon 27 of 35 | 5 | NM_000256.3 | ENSP00000442795.1 | ||
MYBPC3 | ENST00000399249.6 | c.2828G>A | p.Arg943Gln | missense_variant | Exon 26 of 34 | 5 | ENSP00000382193.2 |
Frequencies
GnomAD3 genomes AF: 0.0000329 AC: 5AN: 152176Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000162 AC: 4AN: 247122Hom.: 0 AF XY: 0.00000745 AC XY: 1AN XY: 134292
GnomAD4 exome AF: 0.00000685 AC: 10AN: 1460186Hom.: 0 Cov.: 31 AF XY: 0.00000551 AC XY: 4AN XY: 726374
GnomAD4 genome AF: 0.0000329 AC: 5AN: 152176Hom.: 0 Cov.: 33 AF XY: 0.0000269 AC XY: 2AN XY: 74340
ClinVar
Submissions by phenotype
not specified Uncertain:1
proposed classification - variant undergoing re-assessment, contact laboratory -
Hypertrophic cardiomyopathy 4;C3715165:Left ventricular noncompaction 10 Uncertain:1
- -
Cardiomyopathy Uncertain:1
- -
not provided Uncertain:1
Has been reported in individuals with HCM, sudden unexplained death, and/or cardiomyopathy (PMID: 27532257, 23283745, 32746448, 34816733), some of whom had variants in other genes; Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Functional in vitro studies using a C5C7 construct carrying this variant did not show any impact on cardiac mysoin binding (PMID: 34915024); This variant is associated with the following publications: (PMID: 27532257, 23283745, 32746448, 34915024, 34816733, 33495597) -
Hypertrophic cardiomyopathy Uncertain:1
This sequence change replaces arginine, which is basic and polar, with glutamine, which is neutral and polar, at codon 943 of the MYBPC3 protein (p.Arg943Gln). This variant is present in population databases (rs397515986, gnomAD 0.003%). This missense change has been observed in individual(s) with clinical features of hypertrophic cardiomyopathy and/or pediatric hypertrophic cardiomyopathy (PMID: 23283745, 27532257, 32746448, 37652022). ClinVar contains an entry for this variant (Variation ID: 42659). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Cardiovascular phenotype Uncertain:1
The p.R943Q variant (also known as c.2828G>A), located in coding exon 27 of the MYBPC3 gene, results from a G to A substitution at nucleotide position 2828. The arginine at codon 943 is replaced by glutamine, an amino acid with highly similar properties. This variant has been detected in hypertrophic cardiomyopathy (HCM) cohorts or cohorts referred for HCM genetic testing; however, details were limited and reports may overlap (Zou Y et al. Mol Biol Rep, 2013 Jun;40:3969-76; Walsh R et al. Genet Med, 2017 Feb;19:192-203; Burstein DS et al. Pediatr Res, 2021 May;89:1470-1476; Harper AR et al. Nat Genet, 2021 Feb;53:135-142). This variant has also been detected in a sudden death case with presumed epilepsy (Chahal CAA et al. J Am Heart Assoc, 2021 Dec;10:e021170). One study suggested this variant may not significantly impact certain protein binding interactions; however, the physiological relevance of this finding is unclear (Ponnam S et al. J Biol Chem, 2022 Jan;298:101485). This amino acid position is highly conserved in available vertebrate species. In addition, the in silico prediction for this alteration is inconclusive. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at